Updated Jul 16, 2026
Fletcher Aaron G.L. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying.
Aaron G.L. Fletcher is a corporate insider associated with Cognition Therapeutics Inc and IN8BIO, INC. He holds the roles of 10% Owner and Director in these companies. His involvement is primarily in the biopharmaceutical sector focused on age-related diseases.
| Role | Director, 10% Owner |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | CGTX | COGNITION THERAPEUTICS INC | A — Grant or award | 25.0K | $0.00 | |
| 2025-09-19 | CGTX | COGNITION THERAPEUTICS INC | M — Option exercise | 7.7K | $0.84 | $6K |
Aaron G.L. Fletcher is a corporate insider associated with Cognition Therapeutics Inc and IN8BIO, INC. He holds the roles of 10% Owner and Director in these companies. His involvement is primarily in the biopharmaceutical sector focused on age-related diseases.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases () and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Fletcher Aaron G.L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.